The tragedy of translation: The case of "First use" in human embryonic stem cell research

Jan Helge Solbakk, Laurie Zoloth

Research output: Contribution to journalComment/debatepeer-review

27 Scopus citations

Abstract

Who should go first in phase-I human trials when neither risks nor benefits can be estimated? By assessing concerns raised by Bretzner et al. (2011), we highlight a tragic dimension underlying all such trials. We discuss strategies to avoid the pitfalls of ethical hubris by promoting fidelity and trust.

Original languageEnglish (US)
Pages (from-to)479-481
Number of pages3
JournalCell stem cell
Volume8
Issue number5
DOIs
StatePublished - May 6 2011

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

Fingerprint Dive into the research topics of 'The tragedy of translation: The case of "First use" in human embryonic stem cell research'. Together they form a unique fingerprint.

Cite this